@rektbyhielke@CryptoMichNL Now imagine the virus mutates. Antibodies that worked well before will now work worse or fail. But some of the previously poorly performing antibodies will now turn out to be very cool. And if we have a decent amount of them due to a booster, these will now protect us best.
@rektbyhielke@CryptoMichNL We do not produce just one antibody against a foreign protein, but a collection - some will bind very good (and we will produce lots of these), some worse (and we produce less of them). But even worse binders will be produced more and more with each booster.
@rektbyhielke@CryptoMichNL Antibodies we make to a foreign protein are not 100% specific - they will bind to similar proteins, although often more weakly. Therefore if a virus mutates, antibodies will often still work, but not as well. However, if the protein mutates too much, the binding becomes too weak
@rektbyhielke@CryptoMichNL Exposure to a foreign protein triggers the immune system to make antibodies. Viral proteins are produced by our cells when infected with the virus. We can also inject these proteins with a vaccine or trick our cells to produce them (DNA or RNA vaccines)
@CryptoMichNL In Cardano people are running stakepools on Raspberry Pis.
Meanwhile the Bitcoin people buy expensive and energetically demanding hardware for mining.
Don't compare the incomparable. You're not an epidemiologist.